Related references
Note: Only part of the references are listed.Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model
X. Yu et al.
ONCOGENE (2011)
Regulation of Androgen Receptor Expression Through Angiotensin II Type I Receptor in Prostate Cancer Cells
Koji Hoshino et al.
PROSTATE (2011)
Anti-Proliferative Effect of a Triazole Derivative (ST1959) on LNCaP Human Prostate Cancer Cells Through Down-Regulation of Cyclin and Androgen Receptor Expression
Maria Loiarro et al.
PROSTATE (2011)
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
L. R. Molife et al.
ANNALS OF ONCOLOGY (2010)
A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
Dana Rathkopf et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
1,4-Phenylenebis(Methylene)Selenocyanate, but Not Selenomethionine, Inhibits Androgen Receptor and Akt Signaling in Human Prostate Cancer Cells
Nicole D. Facompre et al.
CANCER PREVENTION RESEARCH (2010)
Androgen Receptor Survival Signaling Is Blocked by Anti-β2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer Cells
Wen-Chin Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
Ankur Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Histone Deacetylase Inhibitor Potentiates Anticancer Effect of Docetaxel via Modulation of Bcl-2 Family Proteins and Tubulin in Hormone Refractory Prostate Cancer Cells
Jung Jin Hwang et al.
JOURNAL OF UROLOGY (2010)
Pharmacological Targeting of Constitutively Active Truncated Androgen Receptor by Nigericin and Suppression of Hormone-Refractory Prostate Cancer Cell Growth
Tetsuo Mashima et al.
MOLECULAR PHARMACOLOGY (2010)
Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression
M. Shiota et al.
ONCOGENE (2010)
MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells
Tsuyoshi Iwata et al.
PLOS ONE (2010)
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
D. Hawksworth et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
8q24 allelic imbalance and MYC gene copy number in primary prostate cancer
H. Chen et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth
Liying Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Vorinostat in Advanced Prostate Cancer Patients Progressing on Prior Chemotherapy (National Cancer Institute Trial 6862) Trial Results and Interleukin-6 Analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium
Deborah Bradley et al.
CANCER (2009)
LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion
Yirong Li et al.
CANCER RESEARCH (2009)
K-ras and Wnt Signaling Synergize to Accelerate Prostate Tumorigenesis in the Mouse
Helen B. Pearson et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
α-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis
Po-Hsien Huang et al.
CARCINOGENESIS (2009)
Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
Wenyan Lu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Regulation of steroid 5-α reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin
Young-Kyo Seo et al.
EXPERIMENTAL CELL RESEARCH (2009)
Activin A Enhances Prostate Cancer Cell Migration Through Activation of Androgen Receptor and Is Overexpressed in Metastatic Prostate Cancer
Hong-Yo Kang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells
Su-Hyeong Kim et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells
Donald J. Vander Griend et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Endothelin-1 Enhances the Expression of the Androgen Receptor Via Activation of the c-myc Pathway in Prostate Cancer Cells
June G. Lee et al.
MOLECULAR CARCINOGENESIS (2009)
Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells
S. Ngan et al.
ONCOGENE (2009)
Nemo-Like Kinase Induces Apoptosis and Inhibits Androgen Receptor Signaling in Prostate Cancer Cells
Katayoon H. Emami et al.
PROSTATE (2009)
Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells
Hui-Qing Yuan et al.
BIOCHEMICAL PHARMACOLOGY (2008)
OSU-HDAC42, a Histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model
Aaron M. Sargeant et al.
CANCER RESEARCH (2008)
Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression
Xuehong Deng et al.
CANCER RESEARCH (2008)
Androgen receptor overexpression in prostate cancer linked to Purα loss from a novel repressor complex
Longgui G. Wang et al.
CANCER RESEARCH (2008)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
Angela Seaton et al.
CARCINOGENESIS (2008)
β2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells
Wen-Chin Huang et al.
CLINICAL CANCER RESEARCH (2008)
The role of histone deacetylases in prostate cancer
Ata Abbas et al.
EPIGENETICS (2008)
Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer
Rumi S. Bhattacharyya et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
The potential role of purine-rich element binding protein (PUR) α as a novel treatment target for hormone-refractory prostate cancer
Takahiro Inoue et al.
PROSTATE (2008)
Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts
Feng-Lan Chiu et al.
PROSTATE (2008)
Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy
Inger L. Rosner et al.
UROLOGY (2007)
Expression of androgen receptor is negatively regulated by p53
Fatouma Alimirah et al.
NEOPLASIA (2007)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
The BH3-only protein Puma plays an essential role in cytokine deprivation-induced apoptosis of mast cells
Maria Ekoff et al.
BLOOD (2007)
Androgen receptor- and E2F-1-targeted thymoquinone therapy for hormone-refractory prostate cancer
Ahmed O. Kaseb et al.
CANCER RESEARCH (2007)
cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis
D. Wu et al.
ONCOGENE (2007)
CREB - a real culprit in oncogenesis
Yeung-Tung Siu et al.
FEBS JOURNAL (2007)
Multiple molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells InVitro and InVivo
Shabana Shabbeer et al.
PROSTATE (2007)
Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer
H-F Yuen et al.
HISTOPATHOLOGY (2007)
Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts
Di Chen et al.
CANCER RESEARCH (2007)
1,1-bis(3′-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor γ-independent pathways
Sudhakar Chintharlapalli et al.
MOLECULAR PHARMACOLOGY (2007)
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation
Deborah L. Marrocco et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Ectopic expression of neurotrophic peptide derived from saposin C increases proliferation and upregulates androgen receptor expression and transcriptional activity in human prostate cancer cells
Yan Ding et al.
ASIAN JOURNAL OF ANDROLOGY (2007)
Integrating cell-signalling pathways with NF-kappa B and IKK function
Neil D. Perkins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms
Clifford G. Tepper et al.
PROSTATE (2007)
Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer
Joanne N. Davis et al.
CANCER RESEARCH (2006)
c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation
S-Y Chen et al.
ONCOGENE (2006)
Introduction to NF-κB:: players, pathways, perspectives
T. D. Gilmore
ONCOGENE (2006)
Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate
L. G. Wang et al.
CARCINOGENESIS (2006)
Androgen activation of the sterol regulatory element-binding protein pathway: Current insights
Hannelore V. Heemers et al.
MOLECULAR ENDOCRINOLOGY (2006)
Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer
Samuel K. Kulp et al.
CLINICAL CANCER RESEARCH (2006)
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
Zongxiang Zhou et al.
CANCER RESEARCH (2006)
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action
Bryan Husbeck et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer
Allan J. Pantuck et al.
CLINICAL CANCER RESEARCH (2006)
Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA)
Soo Ok Lee et al.
PROSTATE (2006)
Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells
Mei-Lan He et al.
CANCER (2006)
Roles and regulation of Wnt signaling and β-catenin in prostate cancer
Meletios Verras et al.
CANCER LETTERS (2006)
Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells
X. Yang et al.
ONCOGENE (2006)
Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells
Rumi S. Bhattacharyya et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy
RS Pruthi et al.
CLINICAL CANCER RESEARCH (2006)
Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer
JY Chun et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells
OW Rokhlin et al.
MOLECULAR CANCER RESEARCH (2006)
Expression of c-jun oncogene in hyperplastic and carcinomatous human prostate
DG Tiniakos et al.
UROLOGY (2006)
Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo
K Shigemura et al.
UROLOGY (2005)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells
JC Hsu et al.
CARCINOGENESIS (2005)
Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells *
L Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer
A Rephaeli et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Transcriptional regulation and transformation by MYC proteins
S Adhikary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
The ErB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells
YX Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
MA Titus et al.
CLINICAL CANCER RESEARCH (2005)
Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target
WK Kwok et al.
CANCER RESEARCH (2005)
Wnt signalling and prostate cancer
GW Yardy et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2005)
Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells
HQ Yuan et al.
CARCINOGENESIS (2005)
Celecoxib inhibits prostate cancer growth: Evidence of a cyclooxygenase-2-independent mechanism
MI Patel et al.
CLINICAL CANCER RESEARCH (2005)
The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation
RL Lynch et al.
MOLECULAR CANCER RESEARCH (2005)
Cell lines used in prostate cancer research: A compendium of old and new lines - Part 1
RE Sobel et al.
JOURNAL OF UROLOGY (2005)
Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence
SL Ettinger et al.
CANCER RESEARCH (2004)
Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer
R Kuefer et al.
BRITISH JOURNAL OF CANCER (2004)
Expression of NF-κB in prostate cancer lymph node metastases
H Ismail et al.
PROSTATE (2004)
Nuclear Factor-κB activates transcription of the androgen receptor gene in sertoli cells isolated from testes of adult rats
LY Zhang et al.
ENDOCRINOLOGY (2004)
Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells
HJ Zhao et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy
RS Pruthi et al.
BJU INTERNATIONAL (2004)
The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP
C Skurk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of c-Jun and c-Fos expression in androgen-independent prostate cancer
J Edwards et al.
JOURNAL OF PATHOLOGY (2004)
Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells
HQ Yuan et al.
CANCER LETTERS (2004)
Up-regulation of Wnt-1 and β-catenin production in patients with advanced metastatic prostate carcinoma -: Potential pathogenetic and prognostic implications
GP Chen et al.
CANCER (2004)
Conditional deletion of Rb causes early stage prostate cancer
LA Maddison et al.
CANCER RESEARCH (2004)
Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate
C Sweeney et al.
CLINICAL CANCER RESEARCH (2004)
Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis
R van Doorn et al.
CANCER RESEARCH (2004)
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas
K Hoek et al.
CANCER RESEARCH (2004)
Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line
LG Wang et al.
ONCOGENE (2004)
Androgen deprivation therapy for prostate cancer: Current status and future prospects
H Miyamoto et al.
PROSTATE (2004)
AP-1 subunits: quarrel and harmony among siblings
J Hess et al.
JOURNAL OF CELL SCIENCE (2004)
High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate - Cancer patients treated with radical prostatectomy
R Li et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Theaflavin-3,3′-digallate and penta-O-galloyl-β-D-glucose inhibit rat liver microsomal 5α-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells
HH Lee et al.
CARCINOGENESIS (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Androgens, lipogenesis and prostate cancer
JV Swinnen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Androgen receptor mutations in androgen-in dependent prostate cancer: Cancer and Leukemia Group B Study 9663
ME Taplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?
IV Litvinov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial
AJ Duffield-Lillico et al.
BJU INTERNATIONAL (2003)
NF-κB nuclear localization and its prognostic significance in prostate cancer
L Lessard et al.
BJU INTERNATIONAL (2003)
The MYC Oncogene as a Cancer Drug Target
Heiko Hermeking
CURRENT CANCER DRUG TARGETS (2003)
Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function
RM Adam et al.
ENDOCRINOLOGY (2002)
Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer
E Rosivatz et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
NF-κB activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer
CD Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Linking β-catenin to androgen-signaling pathway
FJ Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Growth inhibition of glioblastoma cells by human Purα
N Darbinian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines
S Chen et al.
CELL PROLIFERATION (2001)
Translocations involving c-myc and c-myc function
LM Boxer et al.
ONCOGENE (2001)
Safety and efficacy of exisulind for treatment of recurrent prostate cancer after radical prostatectomy
ET Goluboff et al.
JOURNAL OF UROLOGY (2001)
Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer
AR Black et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia
K Lezon-Geyda et al.
LEUKEMIA (2001)
Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells
NZ Xing et al.
CARCINOGENESIS (2001)
Ras-induced colony formation and anchorage-independent growth inhibited by elevated expression of Pur alpha in NIH3T3 cells
SM Barr et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Purα:: a multifunctional single-stranded DNA- and RNA-binding protein
GL Gallia et al.
NUCLEIC ACIDS RESEARCH (2000)
c-Jun targets amino terminus of androgen receptor in regulating androgen-responsive transcription
A Bubulya et al.
ENDOCRINE (2000)
Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues
T Furuyama et al.
BIOCHEMICAL JOURNAL (2000)
Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells
FG Ren et al.
ONCOGENE (2000)
FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapy
C Kaltz-Wittmer et al.
LABORATORY INVESTIGATION (2000)
Share Paper
